EUVIMEDEUVIMED entdecken
Crossref

Cipepofol attenuates endothelial barrier dysfunction in acute lung injury through DUSP1-dependent suppression of MAPK signaling

Shuting Zhou, Xudong He, Xinzhe Ni, Aizhong Wang, Xiaotao Xu

Biochemical Pharmacology · 2026-08 · 250 · 117995

DOI: 10.1016/j.bcp.2026.117995 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2026-08. Verfasst von Shuting Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Sixth People's Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China; Colle…. Hauptthemen laut MEDLINE: Acute Lung Injury, MAP Kinase Signaling System, Dual Specificity Phosphatase 1. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Shanghai Municipal Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular endothelial cell dysfunction leads to the breakdown of endothelial barrier integrity, which contributes to sepsis-induced acute lung injury (ALI). The study investigates the role of Cipepofol in regulating endothelial permeability and inflammation during sepsis using a cecal ligation and puncture (CLP) mouse model and human umbilical vein endothelial cells (HUVECs). Our findings demonstrate that Cipepofol treatment inhibits cytoskeletal stress fiber formation and upregulates junction proteins VE-cadherin, thereby preserving endothelial barrier function. These effects were mediated through the γ-aminobutyric acid type A (GABAA) receptor α1 subunit (GABAA receptor α1). Cipepofol improved sepsis outcomes, including decreased lung injury, leukocyte infiltration, and vascular permeability. Mechanistically, cipepofol-dependent GABAA receptor α1 modulated the expression of dual-specificity phosphatase 1 (DUSP1) in lung tissue and endothelial cells of septic mice. DUSP1 knockdown exacerbated p38 and extracellular signal-regulated kinase (ERK)-MAPK signaling and mitochondrial dysfunction, and abolished the protective effects of Cipepofol against lipopolysaccharide (LPS)-induced mitochondrial oxidative stress. Conversely, genetic or pharmacological inhibition of GABAA receptor α1 reversed Cipepofol-mediated suppression of p38/ERK-MAPK signaling and reactive oxygen species (ROS) accumulation, confirming DUSP1 as a key downstream mediator. Together, our study unveils that Cipepofol preserves endothelial integrity by depending on GABAA receptor α1 to modulate DUSP1 expression, thereby suppressing p38/ERK-MAPK signaling and mitochondrial dysfunction. These findings highlight a potential therapeutic strategy for sepsis-induced ALI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryMAP Kinase Signaling SystemDual Specificity Phosphatase 1AnimalsHumansMaleMiceMice, Inbred C57BLHuman Umbilical Vein Endothelial CellsSepsisReceptors, GABA-ACapillary Permeability

Stichwörter der Autor:innen

Acute lung injuryCipepofolDUSP1GABA(A) receptor α1

Substanzen

Dual Specificity Phosphatase 1Dusp1 protein, mouseDUSP1 protein, humanReceptors, GABA-A

Autor:innen und Institutionen

  • Department of Anesthesiology, Sixth People's Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China; College of Fisheries and Life Science, Shanghai Ocean University, Shanghai…
  • Department of Anesthesiology, Sixth People's Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China. Electronic address: wangaz@sjtu.edu.cn.
  • Department of Anesthesiology, Sixth People's Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China. Electronic address: 2015xuxiaotao@sjtu.edu.cn.

Förderung

  • Shanghai Municipal Natural Science Foundation

Zitieren

APA

Zhou, S., He, X., Ni, X., Wang, A., & Xu, X. (2026). Cipepofol attenuates endothelial barrier dysfunction in acute lung injury through DUSP1-dependent suppression of MAPK signaling. Biochemical Pharmacology, 250, 117995. https://doi.org/10.1016/j.bcp.2026.117995

Vancouver

Zhou S, He X, Ni X, Wang A, Xu X. Cipepofol attenuates endothelial barrier dysfunction in acute lung injury through DUSP1-dependent suppression of MAPK signaling. Biochemical Pharmacology. 2026;250:117995. doi:10.1016/j.bcp.2026.117995

BibTeX
@article{Zhou2026,
  author = {Zhou, Shuting and He, Xudong and Ni, Xinzhe and Wang, Aizhong and Xu, Xiaotao},
  title = {Cipepofol attenuates endothelial barrier dysfunction in acute lung injury through DUSP1-dependent suppression of MAPK signaling},
  journal = {Biochemical Pharmacology},
  year = {2026},
  volume = {250},
  pages = {117995},
  doi = {10.1016/j.bcp.2026.117995}
}
Kostenlos starten →